Lascuña, Judi Ann .

HRN: 26-72-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2025
CEFUROXIME 500MG (TAB)
09/27/2025
10/04/2025
PO
500 Mg
BID
S/P NSVD With RMLE
Remove - Pending Acceptance
09/29/2025
CEFUROXIME 500MG (TAB)
09/29/2025
10/04/2025
PO
500mg
BID
NSVD With RMLE
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: